Lenskart has raised $39.6 million from Chiratae Ventures, DSP India Fund, and Axis Growth Avenues AIF-I, in its fifth funding round this year, according to Inc42. Separately, Entrackr reported that D2C ayurvedic nutrition brand Kapiva is in late-stage talks to raise over $24 million (Rs 200 crore) from OrbiMed.
Lenskart said to have raised $40m
Lenskart, India’s largest eyewear retailer backed by SoftBank Group, has raised $39.6 million from Chiratae Ventures, DSP India Fund, and Axis Growth Avenues AIF-I, in its fifth funding round this year, according to Inc42.
The company has issued over 1.4 million cumulative and fully-convertible preference shares to the investors in the shareholder’s meeting held earlier this month.
Lenskart raised $100 million from Alpha Wave Ventures in April this year, just nine months after raising $315 million at a valuation of $2.5 billion. It raised $24.7 million in the same month from existing investor Epiq Capital. It then raised $25 million and $12.5 million in two separate rounds in the following months.
Lenskart did not respond to a request for comment by DealStreetAsia.
Kapiva to raise over $24m: report
Homegrown D2C ayurvedic nutrition brand Kapiva is in late-stage talks to raise over $24 million (Rs 200 crore) from OrbiMed, according to a report by Entrackr.
“OrbiMed is likely to lead Rs200-250 crore worth Series C round across several tranches in Kapiva,” the report said, citing sources. “Existing investors such as 3one4 Capital and Vertex Ventures will also join the new round.”
Founded in 2015, Kapiva is a modern ayurvedic nutrition brand that offers natural and organic health and skincare products for hair fall, weight loss, digestion, and diabetes in the form of juices, tea, oils, shakes et al. It claims to have over 2 million customers.